Your browser doesn't support javascript.
loading
Real-world data on breast pathologic complete response and disease-free survival after neoadjuvant chemotherapy for hormone receptor-positive, human epidermal growth factor receptor-2-negative breast cancer: a multicenter, retrospective study in China.
Guan, Dandan; Jie, Qiu; Wu, Yihao; Xu, Yuhao; Hong, Weimin; Meng, Xuli.
Affiliation
  • Guan D; General Surgery, Cancer Center, Department of Breast Surgery, Zhejiang Provincial People's Hospital, Hangzhou Medical College, Shangtang Road No. 158, Hangzhou, 310014, Zhejiang, China.
  • Jie Q; Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
  • Wu Y; Zhejiang University of Technology, Hangzhou, Zhejiang, China.
  • Xu Y; Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
  • Hong W; Hangzhou Medical College, Hangzhou, Zhejiang, China.
  • Meng X; General Surgery, Cancer Center, Department of Breast Surgery, Zhejiang Provincial People's Hospital, Hangzhou Medical College, Shangtang Road No. 158, Hangzhou, 310014, Zhejiang, China. mxlmail@126.com.
World J Surg Oncol ; 20(1): 326, 2022 Sep 29.
Article in En | MEDLINE | ID: mdl-36175898
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Triple Negative Breast Neoplasms Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans Country/Region as subject: Asia Language: En Journal: World J Surg Oncol Year: 2022 Type: Article Affiliation country: China
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Triple Negative Breast Neoplasms Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans Country/Region as subject: Asia Language: En Journal: World J Surg Oncol Year: 2022 Type: Article Affiliation country: China